132 related articles for article (PubMed ID: 12239120)
1. Reproductive disturbances, pituitary lactotrope adenomas, and mammary gland tumors in transgenic female mice producing high levels of human chorionic gonadotropin.
Rulli SB; Kuorelahti A; Karaer O; Pelliniemi LJ; Poutanen M; Huhtaniemi I
Endocrinology; 2002 Oct; 143(10):4084-95. PubMed ID: 12239120
[TBL] [Abstract][Full Text] [Related]
2. The permissive role of prolactin as a regulator of luteinizing hormone action in the female mouse ovary and extragonadal tumorigenesis.
Bachelot A; Carré N; Mialon O; Matelot M; Servel N; Monget P; Ahtiainen P; Huhtaniemi I; Binart N
Am J Physiol Endocrinol Metab; 2013 Oct; 305(7):E845-52. PubMed ID: 23921141
[TBL] [Abstract][Full Text] [Related]
3. Human chorionic gonadotropin (hCG) up-regulates wnt5b and wnt7b in the mammary gland, and hCGbeta transgenic female mice present with mammary Gland tumors exhibiting characteristics of the Wnt/beta-catenin pathway activation.
Kuorelahti A; Rulli S; Huhtaniemi I; Poutanen M
Endocrinology; 2007 Aug; 148(8):3694-703. PubMed ID: 17510243
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of human chorionic gonadotropin causes multiple reproductive defects in transgenic mice.
Matzuk MM; DeMayo FJ; Hadsell LA; Kumar TR
Biol Reprod; 2003 Jul; 69(1):338-46. PubMed ID: 12672665
[TBL] [Abstract][Full Text] [Related]
5. Multiple sites of tumorigenesis in transgenic mice overproducing hCG.
Huhtaniemi I; Rulli S; Ahtiainen P; Poutanen M
Mol Cell Endocrinol; 2005 Apr; 234(1-2):117-26. PubMed ID: 15836960
[TBL] [Abstract][Full Text] [Related]
6. Elevated steroidogenesis, defective reproductive organs, and infertility in transgenic male mice overexpressing human chorionic gonadotropin.
Rulli SB; Ahtiainen P; Mäkelä S; Toppari J; Poutanen M; Huhtaniemi I
Endocrinology; 2003 Nov; 144(11):4980-90. PubMed ID: 12960071
[TBL] [Abstract][Full Text] [Related]
7. Persistently expressed human chorionic gonadotropin induces premature luteinization and progressive alterations on the reproductive axis in female mice.
Marcial Lopez A; Ratner LD; Martinez CS; Di Giorgio N; Poutanen M; Huhtaniemi IT; Rulli SB
Gen Comp Endocrinol; 2023 May; 336():114247. PubMed ID: 36858273
[TBL] [Abstract][Full Text] [Related]
8. Genetically modified mouse models addressing gonadotropin function.
Ratner LD; Rulli SB; Huhtaniemi IT
Reprod Biol; 2014 Mar; 14(1):9-15. PubMed ID: 24607250
[TBL] [Abstract][Full Text] [Related]
9. Chronic hypersecretion of luteinizing hormone in transgenic mice disrupts both ovarian and pituitary function, with some effects modified by the genetic background.
Nilson JH; Abbud RA; Keri RA; Quirk CC
Recent Prog Horm Res; 2000; 55():69-89; discussion 89-91. PubMed ID: 11036934
[TBL] [Abstract][Full Text] [Related]
10. Short-term pharmacological suppression of the hyperprolactinemia of infertile hCG-overproducing female mice persistently restores their fertility.
Ratner LD; Gonzalez B; Ahtiainen P; Di Giorgio NP; Poutanen M; Calandra RS; Huhtaniemi IT; Rulli SB
Endocrinology; 2012 Dec; 153(12):5980-92. PubMed ID: 23117930
[TBL] [Abstract][Full Text] [Related]
11. Targeted overexpression of luteinizing hormone causes ovary-dependent functional adenomas restricted to cells of the Pit-1 lineage.
Mohammad HP; Abbud RA; Parlow AF; Lewin JS; Nilson JH
Endocrinology; 2003 Oct; 144(10):4626-36. PubMed ID: 12960102
[TBL] [Abstract][Full Text] [Related]
12. Consequences of elevated luteinizing hormone on diverse physiological systems: use of the LHbetaCTP transgenic mouse as a model of ovarian hyperstimulation-induced pathophysiology.
Mann RJ; Keri RA; Nilson JH
Recent Prog Horm Res; 2003; 58():343-75. PubMed ID: 12795427
[TBL] [Abstract][Full Text] [Related]
13. Fetal but not adult Leydig cells are susceptible to adenoma formation in response to persistently high hCG level: a study on hCG overexpressing transgenic mice.
Ahtiainen P; Rulli SB; Shariatmadari R; Pelliniemi LJ; Toppari J; Poutanen M; Huhtaniemi IT
Oncogene; 2005 Nov; 24(49):7301-9. PubMed ID: 16007123
[TBL] [Abstract][Full Text] [Related]
14. Simian virus 40 T antigen-induced gonadotroph adenomas: a model of human null cell adenomas.
Kumar TR; Graham KE; Asa SL; Low MJ
Endocrinology; 1998 Jul; 139(7):3342-51. PubMed ID: 9645710
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of RCAS1 in human pituitary adenomas.
Umeoka K; Sanno N; Oyama K; Tahara S; Kurotani R; Ikuyama S; Nakashima M; Watanabe T; Osamura RY; Teramoto A
Mod Pathol; 2001 Dec; 14(12):1232-6. PubMed ID: 11743045
[TBL] [Abstract][Full Text] [Related]
16. Ectopic pituitary grafts in mice: hormone levels, effects on fertility, and the development of adenomyosis uteri, prolactinomas, and mammary carcinomas.
Huseby RA; Soares MJ; Talamantes F
Endocrinology; 1985 Apr; 116(4):1440-8. PubMed ID: 3971922
[TBL] [Abstract][Full Text] [Related]
17. Enhanced LH action in transgenic female mice expressing hCGbeta-subunit induces pituitary prolactinomas; the role of high progesterone levels.
Ahtiainen P; Sharp V; Rulli SB; Rivero-Müller A; Mamaeva V; Röyttä M; Huhtaniemi I
Endocr Relat Cancer; 2010 Sep; 17(3):611-21. PubMed ID: 20453081
[TBL] [Abstract][Full Text] [Related]
18. Hyperprolactinemia induced by hCG leads to metabolic disturbances in female mice.
Ratner LD; Stevens G; Bonaventura MM; Lux-Lantos VA; Poutanen M; Calandra RS; Huhtaniemi IT; Rulli SB
J Endocrinol; 2016 Jul; 230(1):157-69. PubMed ID: 27154336
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of rolipram-induced increase in the incidence of mammary adenocarcinoma: histopathological study of a 104-week oral carcinogenicity study in female Sprague-Dawley rats.
Nishiyama S; Okudaira M; Saito N
Arch Toxicol; 2006 Feb; 80(2):88-97. PubMed ID: 16167140
[TBL] [Abstract][Full Text] [Related]
20. Sex differences in the development of prolactinoma in mice overexpressing hCGβ: role of TGFβ1.
Faraoni EY; Camilletti MA; Abeledo-Machado A; Ratner LD; De Fino F; Huhtaniemi I; Rulli SB; Díaz-Torga G
J Endocrinol; 2017 Mar; 232(3):535-546. PubMed ID: 28096433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
